Amylyx: Upgraded To Strong Buy On LUCIDITY Outcome, Avexitide, And 2026 Catalysts (AMLX)
· seekingalpha.com
Amylyx Pharmaceuticals, Inc. upgraded to Strong Buy after phase 3 LUCIDITY avexitide PBH results. Click for this AMLX stock update and see why I am upgrading it.
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you ...